Advertisement
U.S. Markets closed

Morepen Laboratories Limited (MOREPENLAB.BO)

BSE - BSE Real Time Price. Currency in INR
82.35+1.91 (+2.37%)
At close: 03:55PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 44.08B
Enterprise Value 44.20B
Trailing P/E 34.97
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.37
Price/Book (mrq)5.20
Enterprise Value/Revenue 2.63
Enterprise Value/EBITDA 25.61

Trading Information

Stock Price History

Beta (5Y Monthly) 1.45
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3100.80
52 Week Low 335.40
50-Day Moving Average 385.14
200-Day Moving Average 359.60

Share Statistics

Avg Vol (3 month) 31.82M
Avg Vol (10 day) 3831.9k
Shares Outstanding 5547.95M
Implied Shares Outstanding 6N/A
Float 8282.61M
% Held by Insiders 143.70%
% Held by Institutions 11.15%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 18, 2002
Last Split Factor 25:1
Last Split Date 3Nov 07, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 6.70%
Operating Margin (ttm)10.75%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)17.57B
Revenue Per Share (ttm)34.29
Quarterly Revenue Growth (yoy)13.70%
Gross Profit (ttm)N/A
EBITDA 1.81B
Net Income Avi to Common (ttm)1.18B
Diluted EPS (ttm)2.30
Quarterly Earnings Growth (yoy)147.20%

Balance Sheet

Total Cash (mrq)169.45M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)289.99M
Total Debt/Equity (mrq)3.42
Current Ratio (mrq)N/A
Book Value Per Share (mrq)16.57

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A